View in EDS HTML Full Text PDF Full Text

Neoadjuvant Chemoradiotherapy for Oral Cavity Cancer: Predictive Factors for Response and Interim Analysis of the Prospective INVERT-Trial.

Saved in:
Bibliographic Details
Title: Neoadjuvant Chemoradiotherapy for Oral Cavity Cancer: Predictive Factors for Response and Interim Analysis of the Prospective INVERT-Trial.
Authors: von der Grün J; Department of Radiotherapy and Oncology, Goethe-University Frankfurt, Frankfurt, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany.; German Cancer Consortium (DKTK), Partner Site Frankfurt a. M., Goethe-University Frankfurt, Frankfurt, Germany.; Frankfurt Cancer Institute (FCI), Goethe-University Frankfurt, Frankfurt, Germany., Winkelmann R; Dr. Senckenberg Institute of Pathology, Goethe-University Frankfurt, Frankfurt, Germany., Burck I; Department of Diagnostic and Interventional Radiology, Goethe-University Frankfurt, Frankfurt, Germany., Martin D; Department of Radiotherapy and Oncology, Goethe-University Frankfurt, Frankfurt, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany.; German Cancer Consortium (DKTK), Partner Site Frankfurt a. M., Goethe-University Frankfurt, Frankfurt, Germany.; Frankfurt Cancer Institute (FCI), Goethe-University Frankfurt, Frankfurt, Germany., Rödel F; Department of Radiotherapy and Oncology, Goethe-University Frankfurt, Frankfurt, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany.; German Cancer Consortium (DKTK), Partner Site Frankfurt a. M., Goethe-University Frankfurt, Frankfurt, Germany.; Frankfurt Cancer Institute (FCI), Goethe-University Frankfurt, Frankfurt, Germany., Wild PJ; Dr. Senckenberg Institute of Pathology, Goethe-University Frankfurt, Frankfurt, Germany., Bankov K; Dr. Senckenberg Institute of Pathology, Goethe-University Frankfurt, Frankfurt, Germany., Weigert A; Institute of Biochemistry I, Faculty of Medicine, Goethe-University Frankfurt, Frankfurt, Germany., Kur IM; Institute of Biochemistry I, Faculty of Medicine, Goethe-University Frankfurt, Frankfurt, Germany., Brandts C; German Cancer Research Center (DKFZ), Heidelberg, Germany.; German Cancer Consortium (DKTK), Partner Site Frankfurt a. M., Goethe-University Frankfurt, Frankfurt, Germany.; Frankfurt Cancer Institute (FCI), Goethe-University Frankfurt, Frankfurt, Germany.; Department of Medicine, Hematology/Oncology, Goethe-University Frankfurt, Frankfurt, Germany., Filmann N; Institute of Biostatistics and Mathematical Modelling, Goethe-University Frankfurt, Frankfurt, Germany., Issing C; Frankfurt Cancer Institute (FCI), Goethe-University Frankfurt, Frankfurt, Germany.; Department of Otorhinolaryngology, Goethe-University Frankfurt, Frankfurt, Germany., Thönissen P; Department of Oral, Maxillofacial and Facial Plastic Surgery, Goethe-University Frankfurt, Frankfurt, Germany., Tanneberger AM; Department of Oral, Maxillofacial and Facial Plastic Surgery, Goethe-University Frankfurt, Frankfurt, Germany., Rödel C; Department of Radiotherapy and Oncology, Goethe-University Frankfurt, Frankfurt, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany.; German Cancer Consortium (DKTK), Partner Site Frankfurt a. M., Goethe-University Frankfurt, Frankfurt, Germany.; Frankfurt Cancer Institute (FCI), Goethe-University Frankfurt, Frankfurt, Germany., Ghanaati S; Department of Oral, Maxillofacial and Facial Plastic Surgery, Goethe-University Frankfurt, Frankfurt, Germany., Balermpas P; Department of Radiotherapy and Oncology, Goethe-University Frankfurt, Frankfurt, Germany.; Department of Radiation Oncology, University Hospital Zurich, Zurich, Switzerland.
Source: Frontiers in oncology [Front Oncol] 2022 Mar 24; Vol. 12, pp. 817692. Date of Electronic Publication: 2022 Mar 24 (Print Publication: 2022).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 35402268
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Neoadjuvant Chemoradiotherapy for Oral Cavity Cancer: Predictive Factors for Response and Interim Analysis of the Prospective INVERT-Trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22von+der+Grün+J%22">von der Grün J</searchLink>; Department of Radiotherapy and Oncology, Goethe-University Frankfurt, Frankfurt, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany.; German Cancer Consortium (DKTK), Partner Site Frankfurt a. M., Goethe-University Frankfurt, Frankfurt, Germany.; Frankfurt Cancer Institute (FCI), Goethe-University Frankfurt, Frankfurt, Germany.<br /><searchLink fieldCode="AU" term="%22Winkelmann+R%22">Winkelmann R</searchLink>; Dr. Senckenberg Institute of Pathology, Goethe-University Frankfurt, Frankfurt, Germany.<br /><searchLink fieldCode="AU" term="%22Burck+I%22">Burck I</searchLink>; Department of Diagnostic and Interventional Radiology, Goethe-University Frankfurt, Frankfurt, Germany.<br /><searchLink fieldCode="AU" term="%22Martin+D%22">Martin D</searchLink>; Department of Radiotherapy and Oncology, Goethe-University Frankfurt, Frankfurt, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany.; German Cancer Consortium (DKTK), Partner Site Frankfurt a. M., Goethe-University Frankfurt, Frankfurt, Germany.; Frankfurt Cancer Institute (FCI), Goethe-University Frankfurt, Frankfurt, Germany.<br /><searchLink fieldCode="AU" term="%22Rödel+F%22">Rödel F</searchLink>; Department of Radiotherapy and Oncology, Goethe-University Frankfurt, Frankfurt, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany.; German Cancer Consortium (DKTK), Partner Site Frankfurt a. M., Goethe-University Frankfurt, Frankfurt, Germany.; Frankfurt Cancer Institute (FCI), Goethe-University Frankfurt, Frankfurt, Germany.<br /><searchLink fieldCode="AU" term="%22Wild+PJ%22">Wild PJ</searchLink>; Dr. Senckenberg Institute of Pathology, Goethe-University Frankfurt, Frankfurt, Germany.<br /><searchLink fieldCode="AU" term="%22Bankov+K%22">Bankov K</searchLink>; Dr. Senckenberg Institute of Pathology, Goethe-University Frankfurt, Frankfurt, Germany.<br /><searchLink fieldCode="AU" term="%22Weigert+A%22">Weigert A</searchLink>; Institute of Biochemistry I, Faculty of Medicine, Goethe-University Frankfurt, Frankfurt, Germany.<br /><searchLink fieldCode="AU" term="%22Kur+IM%22">Kur IM</searchLink>; Institute of Biochemistry I, Faculty of Medicine, Goethe-University Frankfurt, Frankfurt, Germany.<br /><searchLink fieldCode="AU" term="%22Brandts+C%22">Brandts C</searchLink>; German Cancer Research Center (DKFZ), Heidelberg, Germany.; German Cancer Consortium (DKTK), Partner Site Frankfurt a. M., Goethe-University Frankfurt, Frankfurt, Germany.; Frankfurt Cancer Institute (FCI), Goethe-University Frankfurt, Frankfurt, Germany.; Department of Medicine, Hematology/Oncology, Goethe-University Frankfurt, Frankfurt, Germany.<br /><searchLink fieldCode="AU" term="%22Filmann+N%22">Filmann N</searchLink>; Institute of Biostatistics and Mathematical Modelling, Goethe-University Frankfurt, Frankfurt, Germany.<br /><searchLink fieldCode="AU" term="%22Issing+C%22">Issing C</searchLink>; Frankfurt Cancer Institute (FCI), Goethe-University Frankfurt, Frankfurt, Germany.; Department of Otorhinolaryngology, Goethe-University Frankfurt, Frankfurt, Germany.<br /><searchLink fieldCode="AU" term="%22Thönissen+P%22">Thönissen P</searchLink>; Department of Oral, Maxillofacial and Facial Plastic Surgery, Goethe-University Frankfurt, Frankfurt, Germany.<br /><searchLink fieldCode="AU" term="%22Tanneberger+AM%22">Tanneberger AM</searchLink>; Department of Oral, Maxillofacial and Facial Plastic Surgery, Goethe-University Frankfurt, Frankfurt, Germany.<br /><searchLink fieldCode="AU" term="%22Rödel+C%22">Rödel C</searchLink>; Department of Radiotherapy and Oncology, Goethe-University Frankfurt, Frankfurt, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany.; German Cancer Consortium (DKTK), Partner Site Frankfurt a. M., Goethe-University Frankfurt, Frankfurt, Germany.; Frankfurt Cancer Institute (FCI), Goethe-University Frankfurt, Frankfurt, Germany.<br /><searchLink fieldCode="AU" term="%22Ghanaati+S%22">Ghanaati S</searchLink>; Department of Oral, Maxillofacial and Facial Plastic Surgery, Goethe-University Frankfurt, Frankfurt, Germany.<br /><searchLink fieldCode="AU" term="%22Balermpas+P%22">Balermpas P</searchLink>; Department of Radiotherapy and Oncology, Goethe-University Frankfurt, Frankfurt, Germany.; Department of Radiation Oncology, University Hospital Zurich, Zurich, Switzerland.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101568867%22">Frontiers in oncology</searchLink> [Front Oncol] 2022 Mar 24; Vol. 12, pp. 817692. <i>Date of Electronic Publication: </i>2022 Mar 24 (<i>Print Publication: </i>2022).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101568867 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2234-943X (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222234943X%22">2234943X </searchLink><i>NLM ISO Abbreviation: </i>Front Oncol <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35402268
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fonc.2022.817692
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 817692
    Titles:
      – TitleFull: Neoadjuvant Chemoradiotherapy for Oral Cavity Cancer: Predictive Factors for Response and Interim Analysis of the Prospective INVERT-Trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: von der Grün J
      – PersonEntity:
          Name:
            NameFull: Winkelmann R
      – PersonEntity:
          Name:
            NameFull: Burck I
      – PersonEntity:
          Name:
            NameFull: Martin D
      – PersonEntity:
          Name:
            NameFull: Rödel F
      – PersonEntity:
          Name:
            NameFull: Wild PJ
      – PersonEntity:
          Name:
            NameFull: Bankov K
      – PersonEntity:
          Name:
            NameFull: Weigert A
      – PersonEntity:
          Name:
            NameFull: Kur IM
      – PersonEntity:
          Name:
            NameFull: Brandts C
      – PersonEntity:
          Name:
            NameFull: Filmann N
      – PersonEntity:
          Name:
            NameFull: Issing C
      – PersonEntity:
          Name:
            NameFull: Thönissen P
      – PersonEntity:
          Name:
            NameFull: Tanneberger AM
      – PersonEntity:
          Name:
            NameFull: Rödel C
      – PersonEntity:
          Name:
            NameFull: Ghanaati S
      – PersonEntity:
          Name:
            NameFull: Balermpas P
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 24
              M: 03
              Text: 2022 Mar 24
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-print
              Value: 2234-943X
          Numbering:
            – Type: volume
              Value: 12
          Titles:
            – TitleFull: Frontiers in oncology
              Type: main
ResultId 1